Literature DB >> 19277827

Time of initial appearance of renal symptoms in the course of systemic lupus erythematosus as a prognostic factor for lupus nephritis.

Yuko Takahashi1, Tetsuya Mizoue, Akitake Suzuki, Hiroyuki Yamashita, Junwa Kunimatsu, Kenji Itoh, Akio Mimori.   

Abstract

The prognosis of lupus nephritis (LN) was studied retrospectively in two LN categories, LN manifested initially at systemic lupus erythematosus (SLE) onset (I-LN) and LN of delayed manifestation after SLE onset (D-LN), based on a chart review (C) of 154 SLE (85 LN) patients with a mean observation of 20.8 +/- 9.3 years and a questionnaire study (Q) of 125 LN patients outside our hospital with mean observation of 17.6 +/- 9.2 years. In both study groups, half of I-LN patients were relapse-free by Kaplan-Meier analysis after initial therapy, and the relapsed I-LN patients responded to retherapy at higher 5-year relapse-free rates than those of patients receiving initial therapies for D-LN. At last observation, a higher frequency of prolonged remission was shown in I-LN compared with D-LN patients (C: 22/31, 71% versus 14/49, 29%, P < 0.01; Q: 65/89, 73% versus 11/33, 33% P < 0.01) and also a higher frequency of irreversible renal damage in D-LN compared with I-LN patients (C: 25/49, 51% versus 2/31, 6%, P < 0.001; Q: 14/33, 42% versus 6/89, 7%, P < 0.001), although class IV pathology was common in patients (C) in both LN categories. Onset time of lupus nephritis in the course of SLE may affect renal prognosis.

Entities:  

Mesh:

Year:  2009        PMID: 19277827     DOI: 10.1007/s10165-009-0154-4

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  3 in total

1.  Comparison of renal remission and relapse-free rate in initial- and delayed-onset lupus nephritis.

Authors:  Eiji Suzuki; Makiko Yashiro-Furuya; Jumpei Temmoku; Yuya Fujita; Naoki Matsuoka; Momoko Hazama; Tomoyuki Asano; Shuzo Sato; Hiroko Kobayashi; Hiroshi Watanabe; Takashi Kanno; Kiyoshi Migita
Journal:  Int J Rheum Dis       Date:  2021-10-11       Impact factor: 2.558

2.  Characterization of Patients With Lupus Nephritis Included in a Large Cohort From the Spanish Society of Rheumatology Registry of Patients With Systemic Lupus Erythematosus (RELESSER).

Authors:  María Galindo-Izquierdo; Esther Rodriguez-Almaraz; José M Pego-Reigosa; Francisco J López-Longo; Jaime Calvo-Alén; Alejandro Olivé; Antonio Fernández-Nebro; Víctor Martinez-Taboada; Paloma Vela-Casasempere; Mercedes Freire; Francisco J Narváez; José Rosas; Mónica Ibáñez-Barceló; Esther Uriarte; Eva Tomero; Antonio Zea; Loreto Horcada; Vicenç Torrente; Iván Castellvi; Joan Calvet; Raúl Menor-Almagro; María A Aguirre Zamorano; Enrique Raya; Elvira Díez-Álvarez; Tomás Vázquez-Rodríguez; Paloma García de la Peña; Atusa Movasat; José L Andreu; Patricia Richi; Carlos Marras; Carlos Montilla-Morales; Blanca Hernández-Cruz; José L Marenco de la Fuente; María Gantes; Eduardo Úcar; Juan J Alegre-Sancho; Javier Manero; Jesús Ibáñez-Ruán; Manuel Rodríguez-Gómez; Víctor Quevedo; José Hernández-Beriaín; Lucía Silva-Fernández; Fernando Alonso; Sabina Pérez; Iñigo Rúa-Figueroa
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

3.  Very delayed lupus nephritis: a report of three cases and literature review.

Authors:  André R Alexandre; Pedro L Carreira; David A Isenberg
Journal:  Lupus Sci Med       Date:  2018-01-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.